Trial Profile
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 10 Sep 2009 New trial record